Evolus, Inc.
EOLS$671M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEWPORT BEACH
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
EOLS News
Catalyst Timeline
0 upcoming, 2 past
No catalysts found.
Drug Pipeline
Botulinum toxin, Type A
Glabellar Frown Lines
PrabotulinumtoxinA-Xvfs
Glabellar Frown Lines
Botulinum purified neurotoxin, Type A
Glabellar Frown Lines
DWP-450 (Botulinum purified neurotoxin, Type A)
Glabellar Frown Lines
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Botulinum toxin, Type A | Phase 3 | Glabellar Frown Lines | - | - |
PrabotulinumtoxinA-Xvfs | Phase 2 | Glabellar Frown Lines | - | - |
Botulinum purified neurotoxin, Type A | Phase 2 | Glabellar Frown Lines | - | - |
DWP-450 (Botulinum purified neurotoxin, Type A) | Phase 2 | Glabellar Frown Lines | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply